Clinical Trial Update: A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency [Phase 1]

View source ↗

Summary

Phase 1 multi-dose study assessing tolerability, safety, and pharmacology of the hGH-ViaDerm System in adults with Growth Hormone Deficiency; the trial is repor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• hGH-ViaDerm System

Snippet

Sponsor: Teva Neuroscience, Inc. | Conditions: Growth Hormone Deficiency | Phase 1 | Status: COMPLETED